ArticleScientific reports2025
Clinicopathological analysis of 34 cases of extraocular muscle space-occupying lesions.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To investigate the clinicopathological characteristics and prognosis of extraocular muscle space-occupying lesions. A retrospective study was conducted on 34 patients with pathologically confirmed extraocular muscle space-occupying lesions who underwent ophthalmic surgery at West China Hospital of Sichuan University between January 2010 and December 2024. Clinical data, including demographic characteristics, clinical presentations, imaging features, pathological diagnoses, treatment regimens, and prognosis, were collected and systematically analyzed. Among the 34 patients, 18 were male and 16 were female, with ages ranging from 7 to 78 years (mean age: 48.2 ± 12.5 years). The main clinical manifestations included proptosis (70.6%, 24/34), decreased ocular motility (DOM) (32.4%, 11/34), and eyelid swelling (32.4%, 11/34). The predominant pathological types were inflammatory pseudotumor (38.2%, 13/34; including 5 sclerosing subtype and 8 mixed subtype), hemangioma (20.6%, 7/34), and mucosa-associated lymphoid tissue (MALT) lymphoma (17.6%, 6/34). The lateral rectus muscle was the most frequently involved site (38.2%, 13/34). The primary treatment modalities were surgery combined with glucocorticoids (47.1%, 16/34) or radiotherapy (29.4%, 10/34). Following treatment, 20.6% (7/34) of patients showed significant symptomatic improvement, 44.1% (15/34) achieved stable disease, and 26.5% (9/34) reached complete response. The main pathological types of extraocular muscle space-occupying lesions are inflammatory pseudotumor (sclerosing and mixed subtypes), hemangioma, and MALT lymphoma, with the lateral rectus muscle being most commonly affected. Standardized treatment can lead to favorable clinical outcomes in the majority of patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.